Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:Hallucinogen |
| gptkbp:activeIngredient |
gptkb:lysergic_acid_diethylamide
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
MindMed
|
| gptkbp:has_salt_form |
D-tartrate
|
| gptkbp:investigatedBy |
gptkb:generalized_anxiety_disorder
anxiety disorders |
| gptkbp:relatedTo |
gptkb:LSD
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Mind_Medicine
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
MM-120 (LSD D-tartrate)
|